Related Experiment Video
Updated: Sep 18, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
[Translated article] Update of the Spanish Consensus Document on Infantile Hemangioma
E Baselga1, J Bernabeu-Wittel2, I Betlloch Mas3
1Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
This updated consensus provides guidelines for managing infantile hemangioma (IH), a common pediatric vascular tumor. Early intervention with beta-blockers, like propranolol, and telemedicine improve outcomes for IH patients.
Area of Science:
- Pediatric Oncology
- Dermatology
- Vascular Biology
Background:
- Infantile hemangioma (IH) is the most common pediatric vascular tumor, typically diagnosed clinically.
- While often self-resolving, 10-15% of IH cases lead to severe complications.
- Current literature and expert experience inform updated management strategies for IH.
Framework:
- The IHReS scale is recommended for standardized IH patient referral.
- Telemedicine integration is highlighted for improving IH patient care accessibility.
- Evidence supports the safety and efficacy of beta-blocker therapy for IH.
Implementation:
- Propranolol regimens are extended up to 24 months for sustained IH treatment.
- Clinical practice guidelines emphasize early intervention for better IH outcomes.
- A multidisciplinary expert panel reviewed current scientific literature.
Implications:
- Updated guidelines aim to optimize the management of infantile hemangioma.
- Improved patient outcomes are expected through timely and appropriate IH treatment.
- The consensus promotes standardized care pathways for pediatric vascular tumors.
More Related Videos
Related Concept Videos
Standards of Care II
Standards of Care I
Regulation of Angiogenesis and Blood Supply
Varicose Veins II: Diagnostic Studies and Interprofessional Care
iPS Cell Differentiation

